Maternal Chelation for Embryo and Fetal Benefit
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for diagnosing and treating metal toxins in pregnant women and fetuses, leading to high rates of birth defects, miscarriages, and childhood neurologic dysfunctions, as they rely on limited diagnostic tools like hair analysis and do not effectively quantify or remove metal toxins using chelation treatments.
Innovation Solution
Administering synthetic and proteinaceous chelating agents to pregnant women to identify and remove subclinical levels of heavy metals, using methods such as provocative chelation therapy and urine analysis, to prevent birth defects, miscarriages, and childhood neurologic dysfunctions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If hair analysis is used to diagnose metal toxins, then the diagnostic process is simple and non-invasive, but the measurement precision and ability to quantify metal toxins is insufficient
Solution Approach 1:
The patent uses urine as an intermediary medium to measure metal toxins indirectly. By analyzing metal content in urine samples, the method achieves precise quantification without requiring direct measurement from the fetus or invasive procedures, thus maintaining ease of operation while improving measurement precision
Solution Approach 2:
The patent replaces the mechanical/physical hair analysis method with a biochemical urinalysis approach. This substitution allows for more sensitive and precise detection of metal toxins through chemical analysis of urine samples, improving measurement precision while maintaining operational simplicity
2Object-affected harmful factors
If chelation treatment is administered to remove metal toxins, then the effectiveness in removing toxins increases, but the risk of removing essential minerals increases
Solution Approach 1:
The patent implements a feedback mechanism by monitoring urine metal levels before, during, and after chelation treatment. This allows clinicians to adjust dosing to achieve toxin removal while preventing excessive removal of essential minerals, balancing effectiveness with safety
Solution Approach 2:
The patent changes the parameters of chelation treatment by using lower doses and longer duration protocols compared to traditional aggressive chelation. This modified approach removes metal toxins effectively while minimizing the removal of essential minerals through controlled parameter adjustment
3Reliability
If provocative chelation therapy is used to diagnose and treat metal toxins, then the treatment effectiveness increases, but the complexity of the treatment protocol increases
Solution Approach 1:
The patent merges the diagnostic provocative challenge and therapeutic chelation into a single integrated protocol. By combining diagnosis and treatment phases, the method maintains high reliability through provocative testing while simplifying the overall protocol structure, reducing complexity compared to separate diagnostic and therapeutic regimens
4Reliability
If comprehensive chelation treatment is administered during pregnancy, then the benefit to fetal development increases, but the risk to maternal health increases
Solution Approach 1:
The patent applies partial chelation treatment by using lower doses than would be used for severe maternal toxicity, tailored to subclinical metal levels. This partial action provides sufficient benefit to the fetus while maintaining maternal safety, achieving the right balance between fetal protection and maternal health preservation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed method effectively reduces heavy metal levels in pregnant women and fetuses, potentially leading to improved neurologic development and reduced incidence of birth defects and miscarriages, with benefits extending to enhanced IQ and cognitive function in offspring.
Implementation Method 1
a method of enhancing the embryonic, fetal, conceptus, infant, and human child development by chelation treatment of the mother to remove toxic substances
Data Source
AI summary
This invention teaches the use of chelating agents to diagnose and treat metal toxins in a patient. Chelation agents are given to the mother for the benefit of the baby. Metal toxins such as lead, arsenic, mercury, tin, antimony, aluminum and others are known to cause miscarriages, birth defects, maldevelopment of the organs and tissues and maldevelopment of the brain. Chelation treatments of the mother can prevent these problems in the embryo, fetus and infant. Removal of lead and mercury and other toxins allows improved development of the offspring, both during the chelation and after the chelation is discontinued. Determining whether a mother who has just delivered a baby has elevated levels of heavy metals can also be used to identify the elevated metals of the mother as a possible cause of birth defects.